Iradimed (IRMD) Price to Earnings (2014 - 2026)

Iradimed (IRMD) has reported Price to Earnings for 13 consecutive years, with 234.17 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings rose 77.78% year-over-year to 234.17 in Q2 2026; TTM through Jun 2026 was 53.17, a 39.55% increase from a year earlier, with the FY2025 full-year figure at 55.5, up 47.16% from the prior year.
• Price to Earnings was 234.17 for Q2 2026 at Iradimed, up from 211.49 in the prior quarter.
• Over five years, Price to Earnings peaked at 234.17 in Q2 2026 and troughed at 96.96 in Q4 2022.
• A 5-year average of 153.7 and a median of 143.16 in 2023 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings plunged 46.63% in 2022 and surged 98.8% in 2023, its largest moves.
• Over 5 years, Price to Earnings stood at 96.96 in 2022, then surged by 98.8% to 192.76 in 2023, then retreated by 18.48% to 157.13 in 2024, then grew by 24.28% to 195.29 in 2025, then advanced by 19.91% to 234.17 in 2026.
• The last three Price to Earnings figures came in at 234.17 (Q2 2026), 211.49 (Q1 2026), and 195.29 (Q4 2025), per Business Quant data.